61-75 of 844

RAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG
NeuroFrontiersRAISE Subgroup Analysis: Zilucoplan Without Prior Rescue Therapy in gMG

Next-Generation MS Care: The Promise of Cell-Based Therapeutics
NeuroFrontiersNext-Generation MS Care: The Promise of Cell-Based Therapeutics

Omaveloxolone in Friedreich’s Ataxia: Early Real-World Signals
NeuroFrontiersOmaveloxolone in Friedreich’s Ataxia: Early Real-World Signals

FA hiPSCs in Translational Drug Development
NeuroFrontiersFA hiPSCs in Translational Drug Development

Proactive Pregnancy Planning and Reproductive Care in MS
NeuroFrontiersProactive Pregnancy Planning and Reproductive Care in MS

Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
NeuroFrontiersApplying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
- advertisement

Challenging the Status Quo in Schizophrenia Treatment
On the Frontlines of SchizophreniaChallenging the Status Quo in Schizophrenia Treatment

The Social Brain in Schizophrenia
On the Frontlines of SchizophreniaThe Social Brain in Schizophrenia

Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of SchizophreniaAddressing Social and Systemic Barriers in Schizophrenia

Nutrition and the Gut-Brain Connection in Schizophrenia
On the Frontlines of SchizophreniaNutrition and the Gut-Brain Connection in Schizophrenia

Emerging Serum microRNAs as Early Signals in MS
NeuroFrontiersEmerging Serum microRNAs as Early Signals in MS
- advertisement

Advancing Pediatric MS Care: Insights from AAN 2026
NeuroFrontiersAdvancing Pediatric MS Care: Insights from AAN 2026

Family Planning in Patients with Multiple Sclerosis
NeuroFrontiersFamily Planning in Patients with Multiple Sclerosis





























